Current status of gynecological cancer in China
- PMID: 19590717
- PMCID: PMC2705001
- DOI: 10.3802/jgo.2009.20.2.72
Current status of gynecological cancer in China
Abstract
The aim of this review is to examine the current status of gynecological cancer in China focusing on epidemiological data. Epidemiological data on gynecological cancer in China is sparse. Therefore, most of the data were estimated via extrapolation based on a few available datasets. Cervical cancer is relatively rare and the incidence and mortality rate are largely decreasing. However, in young women, the incidence and mortality rates are increasing. The overall and age-specific incidence rates of cervical cancer appear to be varied according to geographical areas. The overall prevalence rate of human papillomavirus (HPV) in China is similar with other eastern Asian countries, but the age-specific HPV prevalence showed sustained high HPV prevalence rates in elderly women. There is not yet an established national program for cervical cancer prevention. The incidence rate of corpus and ovarian cancers in China slightly increased between 2000 and 2005, but is still lower than Japan or Korea. There is no reliable, national-level data on mortality rates of corpus and ovarian cancer in China. Breast cancer is one of the most rapidly increasing cancers in China. The increase was sharper in young women than in elderly women. Both increased risk and change of population size/structure contributed to the increase of breast cancer.
Keywords: Breast neoplasm; China; Endometrial neoplasm; Epidemiology; Ovarian neoplasm; Uterine cervical neoplasm.
Figures
Similar articles
-
Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.Contraception. 1992 Feb;45(2):93-104. doi: 10.1016/0010-7824(92)90043-s. Contraception. 1992. PMID: 1559340
-
Risk of Anal Cancer in Women With a Human Papillomavirus-Related Gynecological Neoplasm: Puerto Rico 1987-2013.J Low Genit Tract Dis. 2018 Jul;22(3):225-230. doi: 10.1097/LGT.0000000000000395. J Low Genit Tract Dis. 2018. PMID: 29649025
-
Temporal trends and projections of gynecological cancers in China, 2007-2030.BMC Womens Health. 2023 Jun 30;23(1):346. doi: 10.1186/s12905-023-02384-2. BMC Womens Health. 2023. PMID: 37391767 Free PMC article.
-
Global burden of human papillomavirus and related diseases.Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Vaccine. 2012. PMID: 23199955 Review.
-
Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis.Sex Transm Infect. 2018 Sep;94(6):434-442. doi: 10.1136/sextrans-2017-053412. Epub 2018 May 24. Sex Transm Infect. 2018. PMID: 29794242
Cited by
-
Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients.Onco Targets Ther. 2013 Oct 30;6:1539-43. doi: 10.2147/OTT.S52805. eCollection 2013. Onco Targets Ther. 2013. PMID: 24204164 Free PMC article.
-
MiR-124 inhibits invasion and induces apoptosis of ovarian cancer cells by targeting programmed cell death 6.Oncol Lett. 2017 Dec;14(6):7311-7317. doi: 10.3892/ol.2017.7157. Epub 2017 Oct 10. Oncol Lett. 2017. PMID: 29344168 Free PMC article.
-
Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.Medicine (Baltimore). 2016 Jan;95(3):e2555. doi: 10.1097/MD.0000000000002555. Medicine (Baltimore). 2016. PMID: 26817906 Free PMC article.
-
Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015.Sci Rep. 2017 Nov 1;7(1):14813. doi: 10.1038/s41598-017-13299-y. Sci Rep. 2017. PMID: 29093458 Free PMC article.
-
CacyBP/SIP expression is involved in the clinical progression of breast cancer.World J Surg. 2010 Nov;34(11):2545-52. doi: 10.1007/s00268-010-0690-2. World J Surg. 2010. PMID: 20585948
References
-
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150. - PubMed
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156. - PubMed
-
- WHO. Geneva: World Health Organization; c2003-2005. [cited 2009 May 29]. Country Cooperation Strategy at a glance, China [Internet] Available from http://www.who.int/countries/chn/en/
-
- Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243–250. - PubMed